Invesco NASDAQ Biotech ETF (LSE:SBIO) - ETF price - Overview


ETF Report

Invesco NASDAQ Biotech UCITS ETF SBIO

Closing Price
USD34.72

1 Day Change
0.00|0.00%

As of 22/04/2019

Last Close34.72
52-Wk Range28.96 - 39.33
Yield %0.00
ISINIE00BQ70R696
Volume85,512
Premium %3.42

Growth Of 10,000 (USD) 31/03/2019

HowHasThisSecurityPerformed
201420152016201720182019
Fund-11.25-21.3121.45-11.3416.12
Category-7.21-19.4920.75-13.3516.57
Benchmark-7.66-12.1618.19-4.283.52
  • Fund: Invesco NASDAQ Biotech UCITS ETF
  • Category: Sector Equity Biotechnology
  • Benchmark: MSCI World/Biotechnology NR USD
Trailing Returns % (USD) 22/04/2019
FundCatBmark
YTD13.3912.69-1.94
3 Years Annualised4.753.931.71
5 Years Annualised---
10 Years Annualised---
Key Stats
Morningstar® CategorySector Equity Biotechnology
ISINIE00BQ70R696
NAV 22/04/2019USD 34.72
Day Change0.00%
12 Month Yield0.00%
Dividend Frequency-
Net Assets (mil) 31/03/2019336.77 USD
Total Expense Ratio0.40%
Initial Charge-
Exit Charge-
Manager Name-
Inception Date07/11/2014

Morningstar Rating™

StarRatingValueLabel_3

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Benchmarks

Fund Benchmark

NASDAQ Biotechnology TR USD

Morningstar® Benchmark

MSCI World/Biotechnology NR USD

Investment Objective

The Fund aims to provide the performance of the NASDAQ Biotechnology Index1 (the “Benchmark Index”). The Benchmark Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market.

Portfolio Profile31/03/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
TRS NASDAQ Biotechnology TR USD Not Classified100.00
Asset Allocation %
LongShortNet
Stocks100.000.00100.00
Bonds0.000.000.00
Cash0.000.000.00
Other0.000.000.00
Top Stock Regions
Region%
United States94.29
United Kingdom2.68
Asia - Emerging1.21
Eurozone1.00
Asia - Developed0.30
Top Stock Sectors
Stock Sectors%
Healthcare99.98
Basic Materials0.02
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.